David Chu
Stony Brook University Hospital(US)Stony Brook School(US)Stony Brook University(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Colorectal Cancer Treatments and Studies, Monoclonal and Polyclonal Antibodies Research, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients(2008)761 cited
- → Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis(2009)418 cited
- → Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer(2014)393 cited
- → Risk of hand-foot skin reaction with sorafenib: A systematic review and meta-analysis(2008)196 cited
- → Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis(2010)182 cited
- → Inhibitory Effect of Epinephrine on Insulin-stimulated Glucose Uptake by Rat Skeletal Muscle(1981)179 cited